$HOODBullishMed

Global Markets: Australia shares log worst week in nearly a month with US-Iran talks stuck in limbo

Australia’s S&P/ASX 200 fell 0.7% to 8,625.10 on Friday, its lowest close since May 28, and logged its worst week in nearly a month. The index was down 1.2% for the week. The slide followed U.S.-Iran peace talks stalling amid U.S./Israel and Hezbollah ceasefire disputes, while resources and financials declined.

6/10
4/10
Med
Bullish
ahead of the weekend as US-Iran peace-deal hopes remain stuck
risk-off with defensive pockets (healthcare/staples) and cyclical/commodity-linked weakness

HOOD’s strength contrasts with risk-off tone, implying selective buying in high-beta/retail-linked names.

Robinhood Markets is shown as a top gainer (+6.61%) during a session where geopolitical headlines pressured broader markets.

Short-term momentum possible; sensitive to any reversal in risk appetite.

Background

The piece links market weakness to escalating US-Iran tensions and a stalled peace-deal narrative, alongside Lebanon ceasefire rejection and Israel’s troop stance.

Why it matters

Geopolitical uncertainty is pressuring Australian equities and contributing to a risk-off rotation globally; commodity-linked names fall with weaker metals, while some defensives outperform.

Market relevance

Traders may use the article as a read-through for risk appetite, commodity sensitivity, and defensive rotation into healthcare/staples versus resources/financials.

Market effects

Geopolitical escalation and oil/commodity concerns are driving cross-asset risk rotation: financials/resources weaker; healthcare/staples relatively resilient.

Australia’s ASX 200 posts worst week in nearly a month; New Zealand’s NZX 50 is slightly down on the week.

US-Iran talks limbo and Lebanon ceasefire rejection feed into global risk appetite and commodity/energy expectations.

Alternative perspectives

Some top gainers (healthcare/alternatives) may reflect stock-specific positioning rather than pure macro hedging, so index-level risk-off may not translate uniformly to all defensives.

The article doesn’t specify drivers behind individual large-cap losers (e.g., AVGO/MU/APTV), so attributing moves solely to geopolitics could misread idiosyncratic catalysts.

Key entities

  • US-Iran talks

    Peace-deal hopes are described as stuck in limbo, weighing on risk sentiment.

  • Hezbollah ceasefire rejection

    Hezbollah’s rejection in Lebanon undermines US efforts to halt fighting with Tehran.

  • Commonwealth Bank of Australia

    Cited down 1.7% as Australian financials log a second week in the red.

Related articles

$NVDAMed

$1.3 trillion wiped off Wall Street as AI rally slows; Nvidia slips 6%, Micron falls 13%

US tech and semiconductor stocks fell sharply on Friday as investors cooled on AI-driven valuations and digested stronger US jobs data. The PHLX Semiconductor Index dropped 10.3% (steepest since March 2020), extending a two-day slide that erased about 12% and ~$1.3 trillion in chipmakers’ value. Nvidia fell ~6%, Micron 13%, Marvell 17%, AMD ~11%, and Broadcom 7.9%. The Nasdaq fell 1.4% and S&P 500 0.7%.

$NVDAMed

US Stock Market Tumbles as Tech and Semiconductor Stocks Lead Massive Selloff

U.S. stocks fell sharply on Friday, ending a nine-week winning streak as technology and semiconductor shares led losses. The Nasdaq dropped 4.18% to 25,709.43, the S&P 500 fell 2.64% to 7,383.74, and the Dow fell 1.35% to 50,866.78. The Labor Department said May jobs rose 172,000, above forecasts, raising expectations the Fed may keep rates higher longer. The Philadelphia Semiconductor Index fell over 11%, with major chipmakers including Nvidia, Intel, AMD, Micron, and Broadcom down.

$AXONMedAI 9/10

Axon Enterprise Touts AI, Global Markets and Counter-Drone Demand as Growth Engines

Axon Enterprise President Josh Isner said the company is seeing growth across U.S. public safety, international, enterprise customers and counter-drone products, according to a William Blair fireside chat. He cited international bookings of $1 billion+ in 2023, AI tools bookings of $750 million+ last year, and Q1 AI bookings up 140% y/y. Adjusted EBITDA margins rose to 25.5% this year, with 28% guided for 2028.